BOSTON (AP) _ Akcea Therapeutics Inc. (AKCA) on Tuesday reported a loss of $49.6 million in its second quarter.

The Boston-based company said it had a loss of 64 cents per share.

The biopharmaceutical company posted revenue of $22.4 million in the period.

Akcea Therapeutics shares have decreased 34% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $11.19, a decline of 43% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKCA at https://www.zacks.com/ap/AKCA

© 2020 The Canadian Press. All rights reserved., source Canadian Press DataFile